Litcius/Paper detail

STereotactic Ablative RadioTherapy in NEWly Diagnosed and Recurrent Locally Advanced Non-Small Cell Lung Cancer Patients Unfit for ConcurrEnt RAdio-Chemotherapy: Early Analysis of the START-NEW-ERA Non-Randomised Phase II Trial

Fabio Arcidiacono, Paola Anselmo, Michelina Casale, Cristina Zannori, Mark Ragusa, Francesco Mancioli, Giovanni M. Marchetti, Fabio Loreti, M. Italiani, Sergio Bracarda, Ernesto Maranzano, Fabio Trippa

2022International Journal of Radiation Oncology*Biology*Physics18 citationsDOI

Topics & Concepts

MedicineHazard ratioLung cancerRadiation therapySABR volatility modelInternal medicineChemotherapyPhases of clinical researchConfidence intervalSurgeryOncologyEconomicsFinancial economicsVolatility (finance)Stochastic volatilityLung Cancer Diagnosis and TreatmentBrain Metastases and TreatmentHepatocellular Carcinoma Treatment and Prognosis
STereotactic Ablative RadioTherapy in NEWly Diagnosed and Recurrent Locally Advanced Non-Small Cell Lung Cancer Patients Unfit for ConcurrEnt RAdio-Chemotherapy: Early Analysis of the START-NEW-ERA Non-Randomised Phase II Trial | Litcius